Why Should Investors Try CFD Trading?

Published 09-MAY-2016 15:23 P.M.

|

3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

On account of Australia’s reliance on the world’s second-biggest economy, a hard landing in China could cause a domestic recession according to Oxford Economics. But while rate cuts by the Reserve Bank of Australia and a drop in currency could also encourage a quick recovery, several investors are naturally already choosing to explore alternative financial opportunities.

One of which is Contracts for Difference or CFD trading. In essence, CFDs allow you to open a contract for the difference in price of an asset, from the point of opening to when you close. But why should investors try CFD trading against a backdrop of global financial uncertainty?

CFDs are a leveraged product

Arguably the most advantageous reason to choose CFDs is that they provide a much higher leverage than traditional trading. Although a lot depends on the underlying asset (for example stocks and shares), standard leverage in the CFD market begins as low as a 2 per cent. This means less capital outlay for the investor and greater potential returns.

Many traders are only interested in CFDs as they allow you to take advantage of small price movements with small amounts of money. However, a larger leverage can increase losses, so CFDs require a high level of risk management too.

Global market access and a variety of trading options

With most CFD brokers offering products in all the world’s major financial markets, investors can trade almost any market as long as it’s open.

In addition to global market access from a single platform, a variety of trading options are available too. These include stock, index, treasury, currency, and commodity CFDs. As a result, both stock traders and investors of other financial vehicles can benefit from CFD trading.

No shorting rules or borrowing costs

Investors will know that certain markets have rules that do not allow shorting at certain times. Then again, some markets will require the trader to borrow the instrument before shorting, while others have different margin requirements.

But generally speaking, CFD trading involves no rules like this, allowing investors to short an instrument at any time. On top of that, there is no borrowing or shorting costs either, as you don’t actually own the underlying asset.

No trading fees

Rather than charging commissions or fees to enter or exit a trade, several CFD brokers make money by getting investors to pay the spread instead.

Traders must pay the ask price, but to sell/short, must take the bid price. This spread may also be small or large depending on the volatility of the underlying asset, but it is almost always a fixed spread.

No day trading requirements

With some markets, you will need a minimum amount of capital to day trade or only be allowed to make a certain amount of day trades within certain accounts.

However, the same can’t be said with the CFD market, which is not bound by these restrictions or requirements. While minimum deposit amounts do exist, they can often be as little as $1000.

For more information about trading CFDs, read the Australian Securities & Investments Commission’s guide.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X